NACL Industries Ltd
NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]
- Market Cap ₹ 1,061 Cr.
- Current Price ₹ 53.1
- High / Low ₹ 85.0 / 48.6
- Stock P/E
- Book Value ₹ 25.4
- Dividend Yield 0.00 %
- ROCE -0.04 %
- ROE -10.8 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 7.21% over last 3 years.
- Company has high debtors of 157 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
601 | 636 | 746 | 692 | 735 | 847 | 865 | 1,015 | 1,191 | 1,633 | 2,116 | 1,779 | 1,588 | |
583 | 625 | 701 | 636 | 679 | 798 | 852 | 946 | 1,078 | 1,495 | 1,922 | 1,762 | 1,536 | |
Operating Profit | 18 | 11 | 44 | 56 | 56 | 49 | 14 | 69 | 113 | 138 | 193 | 17 | 51 |
OPM % | 3% | 2% | 6% | 8% | 8% | 6% | 2% | 7% | 10% | 8% | 9% | 1% | 3% |
18 | 16 | 26 | 18 | 41 | 20 | 27 | 8 | 15 | 13 | 10 | 10 | 12 | |
Interest | 31 | 28 | 35 | 37 | 38 | 33 | 34 | 29 | 28 | 27 | 47 | 76 | 74 |
Depreciation | 25 | 22 | 25 | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 28 | 27 | 28 |
Profit before tax | -20 | -23 | 10 | 11 | 31 | 15 | -13 | 24 | 75 | 100 | 128 | -76 | -38 |
Tax % | -36% | -9% | 27% | 18% | -4% | 25% | -48% | 30% | 32% | 26% | 26% | -23% | |
-13 | -21 | 8 | 10 | 33 | 12 | -7 | 17 | 51 | 73 | 95 | -59 | -31 | |
EPS in Rs | -0.70 | -1.32 | 0.54 | 0.62 | 2.09 | 0.74 | -0.42 | 0.87 | 2.60 | 3.70 | 4.77 | -2.96 | -1.54 |
Dividend Payout % | 0% | 0% | 19% | 16% | 6% | 17% | 0% | 12% | 15% | 15% | 15% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 16% |
3 Years: | 14% |
TTM: | -22% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -292% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 15% |
3 Years: | -8% |
1 Year: | -30% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 8% |
3 Years: | 7% |
Last Year: | -11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 16 | 16 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | 20 | 20 | 20 |
Reserves | 180 | 159 | 162 | 170 | 213 | 223 | 267 | 338 | 399 | 469 | 554 | 491 | 486 |
177 | 219 | 228 | 232 | 213 | 237 | 210 | 268 | 202 | 531 | 724 | 789 | 522 | |
228 | 227 | 260 | 193 | 209 | 237 | 248 | 330 | 355 | 496 | 616 | 518 | 617 | |
Total Liabilities | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,516 | 1,914 | 1,818 | 1,645 |
172 | 182 | 176 | 167 | 163 | 158 | 141 | 191 | 220 | 238 | 402 | 439 | 457 | |
CWIP | 11 | 18 | 12 | 6 | 7 | 5 | 21 | 42 | 36 | 116 | 71 | 47 | 29 |
Investments | 4 | 9 | 12 | 13 | 9 | 9 | 14 | 15 | 16 | 13 | 14 | 15 | 15 |
413 | 411 | 466 | 426 | 473 | 541 | 566 | 707 | 704 | 1,148 | 1,427 | 1,318 | 1,144 | |
Total Assets | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,516 | 1,914 | 1,818 | 1,645 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
76 | 31 | 40 | 46 | 58 | 24 | 36 | 103 | 83 | -124 | -20 | 50 | |
-5 | -47 | -18 | -12 | -6 | -14 | -27 | -97 | 14 | -163 | -143 | -38 | |
-74 | 11 | -27 | -33 | -58 | -11 | -9 | 70 | -113 | 290 | 134 | -22 | |
Net Cash Flow | -3 | -5 | -4 | 1 | -5 | -1 | 0 | 77 | -16 | 2 | -28 | -9 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 100 | 92 | 108 | 99 | 110 | 124 | 113 | 129 | 103 | 118 | 133 | 157 |
Inventory Days | 154 | 140 | 138 | 153 | 189 | 141 | 134 | 84 | 100 | 124 | 112 | 92 |
Days Payable | 113 | 97 | 121 | 89 | 127 | 127 | 125 | 137 | 120 | 112 | 110 | 87 |
Cash Conversion Cycle | 141 | 135 | 125 | 163 | 172 | 137 | 122 | 76 | 83 | 129 | 135 | 162 |
Working Capital Days | 97 | 93 | 90 | 119 | 126 | 124 | 125 | 90 | 89 | 123 | 128 | 148 |
ROCE % | 3% | 2% | 11% | 12% | 10% | 11% | 4% | 10% | 17% | 15% | 15% | -0% |
Documents
Announcements
-
Receipt Of Communication By Way Of E-Mails From BSE And NSE Regarding Alleged Non-Compliance Of Regulation 19 Of The Listing Regulations, 2015.
22 Nov - Received penalty for non-compliance with Regulation 19.
-
NACL Industries Limited Has informed About The Application For Inprinciple Approval For Employee Stock Option Scheme 2020 Received From Stock Exchanges.
13 Nov - In-principal approval for Employee Stock Option Scheme 2020.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 4 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Oct - NACL Industries Limited has informed about copy of Newspaper Publication.
-
Unaudited Financial Results (Standalone And Consolidated) For The Second Quarter And Half Year Ended September 30, 2024
24 Oct - Approved un-audited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024TranscriptNotesPPT
-
Jan 2024TranscriptNotesPPT
-
Sep 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Mar 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
Products[1]
Key technicals:
Insecticides: Cairo, Fenny, Nagarjuna 4G, PestLock, etc.
Herbicides: Font, Slogan, Nagarjuna Combi plus, etc.
Fungicides: Combi plus, Kazan, Result, Subtle Plant Growth Regulators :Atonik, Gallant EG, Gallant Gold
Company has 63 branded products.[2]